| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.93 | 0 | 0.93 | Vitamin D receptor agonist | 0.823 0 DBMET00575 | ||
| 0.893 | 0.004 | 0.893 | Immunomodulator | 0.869 0.004 DBMET00575 | ||
| 0.882 | 0.006 | 0.882 | Antiinflammatory | 0.858 0.009 DBMET00575 | ||
| 0.866 | 0.003 | 0.904 | Non-steroidal antiinflammatory agent | 0.904 0.002 DBMET00575 | DBMET00575 | |
| 0.863 | 0.009 | 0.863 | Transcription factor NF kappa B inhibitor | 0.858 0.009 DBMET00575 | ||
| 0.825 | 0.001 | 0.825 | Interferon gamma antagonist | 0.705 0.001 DBMET00575 | ||
| 0.796 | 0.001 | 0.796 | Calcium channel activator | 0.642 0.002 DBMET00575 | ||
| 0.804 | 0.01 | 0.804 | Caspase 9 stimulant | 0.557 0.043 DBMET00575 | ||
| 0.782 | 0 | 0.782 | Vitamin D-like | 0.399 0 DBMET00575 | ||
| 0.795 | 0.017 | 0.795 | Apoptosis agonist | 0.729 0.026 DBMET00575 | ||
| 0.761 | 0 | 0.761 | Vitamin D receptor antagonist | 0.688 0 DBMET00575 | ||
| 0.75 | 0 | 0.75 | Parathyroid hormone antagonist | 0.682 0 DBMET00575 | ||
| 0.73 | 0.003 | 0.804 | Interleukin agonist | 0.804 0.002 DBMET00575 | DBMET00575 | |
| 0.724 | 0.005 | 0.724 | Immunosuppressant | 0.703 0.005 DBMET00575 | ||
| 0.646 | 0.02 | 0.668 | Cyclophilin D inhibitor | 0.668 0.018 DBMET00575 | DBMET00575 | |
| 0.573 | 0.004 | 0.58 | Bone formation stimulant | 0.58 0.004 DBMET00575 | DBMET00575 | |
| 0.567 | 0.001 | 0.575 | CYP24 inhibitor | 0.575 0.001 DBMET00575 | DBMET00575 | |
| 0.547 | 0.002 | 0.547 | Progesterone antagonist | 0.403 0.003 DBMET00575 | ||
| 0.566 | 0.023 | 0.622 | Cholesterol antagonist | 0.622 0.016 DBMET00575 | DBMET00575 | |
| 0.543 | 0.002 | 0.579 | Keratolytic | 0.579 0.002 DBMET00575 | DBMET00575 | |
| 0.516 | 0.003 | 0.516 | Sodium/bile acid cotransporter inhibitor | 0.513 0.003 DBMET00575 | ||
| 0.497 | 0.016 | 0.497 | Nitric oxide antagonist | 0.452 0.02 DBMET00575 | ||
| 0.491 | 0.013 | 0.491 | Hypolipemic | 0.428 0.02 DBMET00575 | ||
| 0.471 | 0.004 | 0.471 | T cell inhibitor | 0.41 0.004 DBMET00575 | ||
| 0.469 | 0.003 | 0.469 | Cholesterol synthesis inhibitor | 0.39 0.005 DBMET00575 | ||
| 0.449 | 0.004 | 0.449 | ABCA1 expression enhancer | 0.405 0.004 DBMET00575 | ||
| 0.428 | 0.004 | 0.428 | Androgen antagonist | 0.239 0.01 DBMET00575 | ||
| 0.386 | 0.01 | 0.386 | Lipocortins synthesis antagonist | 0.383 0.01 DBMET00575 | ||
| 0.419 | 0.044 | 0.419 | Immunostimulant | 0.375 0.057 DBMET00575 | ||
| 0.375 | 0.004 | 0.375 | Farnesoid X receptor antagonist | 0.361 0.004 DBMET00575 | ||
| 0.424 | 0.066 | 0.434 | Antibacterial | 0.434 0.063 DBMET00575 | DBMET00575 | |
| 0.397 | 0.039 | 0.472 | Apoptosis antagonist | 0.472 0.024 DBMET00575 | DBMET00575 | |
| 0.356 | 0.003 | 0.356 | Pregnane X receptor agonist | 0.241 0.005 DBMET00575 | ||
| 0.351 | 0.001 | 0.351 | Anabolic | 0.255 0.002 DBMET00575 | ||
| 0.358 | 0.023 | 0.358 | Anesthetic general | 0.231 0.059 DBMET00575 | ||
| 0.353 | 0.019 | 0.353 | Hepatoprotectant | 0.343 0.02 DBMET00575 | ||
| 0.346 | 0.034 | 0.358 | Angiogenesis stimulant | 0.358 0.03 DBMET00575 | DBMET00575 | |
| 0.315 | 0.012 | 0.317 | Antipruritic | 0.317 0.012 DBMET00575 | DBMET00575 | |
| 0.297 | 0.004 | 0.297 | CDC25A inhibitor | 0.295 0.004 DBMET00575 | ||
| 0.338 | 0.05 | 0.338 | Antioxidant | 0.312 0.057 DBMET00575 | ||
| 0.296 | 0.019 | 0.296 | Amylase inhibitor | 0.259 0.025 DBMET00575 | ||
| 0.325 | 0.068 | 0.325 | Caspase 3 stimulant | |||
| 0.254 | 0.008 | 0.254 | Microtubule formation inhibitor | 0.252 0.008 DBMET00575 | ||
| 0.264 | 0.026 | 0.264 | Growth factor agonist | 0.249 0.032 DBMET00575 | ||
| 0.293 | 0.056 | 0.293 | Tumour necrosis factor alpha release inhibitor | 0.216 0.096 DBMET00575 | ||
| 0.24 | 0.005 | 0.24 | Interleukin 12 antagonist | 0.159 0.01 DBMET00575 | ||
| 0.221 | 0.009 | 0.221 | Antineoplastic alkaloid | 0.107 0.044 DBMET00575 | ||
| 0.217 | 0.019 | 0.234 | Arachidonic acid antagonist | 0.234 0.01 DBMET00575 | DBMET00575 | |
| 0.308 | 0.111 | 0.308 | Antiobesity | 0.238 0.168 DBMET00575 | ||
| 0.226 | 0.031 | 0.289 | Phospholipase C inhibitor | 0.289 0.019 DBMET00575 | DBMET00575 | |
| 0.214 | 0.022 | 0.214 | Neurotrophic factor | 0.142 0.067 DBMET00575 | ||
| 0.185 | 0.005 | 0.287 | 5-Alpha-reductase inhibitor | 0.287 0.003 DBMET00575 | DBMET00575 | |
| 0.201 | 0.028 | 0.207 | DNA polymerase I inhibitor | 0.207 0.026 DBMET00575 | DBMET00575 | |
| 0.2 | 0.041 | 0.2 | Melanin inhibitor | 0.153 0.077 DBMET00575 | ||
| 0.211 | 0.057 | 0.211 | P-glycoprotein inhibitor | 0.187 0.074 DBMET00575 | ||
| 0.196 | 0.043 | 0.247 | Protein kinase stimulant | 0.247 0.027 DBMET00575 | DBMET00575 | |
| 0.155 | 0.005 | 0.16 | Na+ K+ transporting ATPase inhibitor | 0.16 0.004 DBMET00575 | DBMET00575 | |
| 0.23 | 0.083 | 0.23 | DNA synthesis inhibitor | 0.219 0.096 DBMET00575 | ||
| 0.153 | 0.007 | 0.265 | Bile acid receptor antagonist | 0.265 0.003 DBMET00575 | DBMET00575 | |
| 0.251 | 0.117 | 0.33 | Interleukin 2 agonist | 0.33 0.055 DBMET00575 | DBMET00575 | |
| 0.204 | 0.073 | 0.204 | Neurotrophic factor enhancer | |||
| 0.13 | 0.01 | 0.131 | Glycine receptor agonist | 0.131 0.01 DBMET00575 | DBMET00575 | |
| 0.152 | 0.032 | 0.152 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.16 | 0.042 | 0.186 | Protein-tyrosine phosphatase 1B inhibitor | 0.186 0.033 DBMET00575 | DBMET00575 | |
| 0.127 | 0.01 | 0.127 | CDC25B inhibitor | 0.12 0.011 DBMET00575 | ||
| 0.142 | 0.033 | 0.142 | Antineoplastic antibiotic | 0.131 0.035 DBMET00575 | ||
| 0.124 | 0.037 | 0.124 | Hedgehog signaling inhibitor | |||
| 0.094 | 0.008 | 0.094 | Liver X receptor agonist | 0.043 0.032 DBMET00575 | ||
| 0.089 | 0.005 | 0.093 | Farnesoid X receptor agonist | 0.093 0.004 DBMET00575 | DBMET00575 | |
| 0.098 | 0.015 | 0.098 | Androgen agonist | 0.074 0.027 DBMET00575 | ||
| 0.153 | 0.075 | 0.187 | Protein-tyrosine phosphatase inhibitor | 0.187 0.052 DBMET00575 | DBMET00575 | |
| 0.077 | 0.006 | 0.15 | 5-Alpha-reductase 2 inhibitor | 0.15 0.004 DBMET00575 | DBMET00575 | |
| 0.081 | 0.013 | 0.081 | Lipocortins synthesis agonist | 0.081 0.013 DBMET00575 | ||
| 0.102 | 0.035 | 0.119 | Inducible nitric-oxide synthase inhibitor | 0.119 0.025 DBMET00575 | DBMET00575 | |
| 0.085 | 0.019 | 0.107 | Prostaglandin F2 alpha antagonist | 0.107 0.009 DBMET00575 | DBMET00575 | |
| 0.068 | 0.004 | 0.068 | HMG CoA reductase inhibitor | 0.067 0.004 DBMET00575 | ||
| 0.063 | 0.011 | 0.063 | Liver X receptor alpha agonist | 0.041 0.028 DBMET00575 | ||
| 0.071 | 0.024 | 0.075 | Heme oxygenase stimulant | 0.075 0.019 DBMET00575 | DBMET00575 | |
| 0.06 | 0.014 | 0.06 | Microtubule stabilization | 0.059 0.016 DBMET00575 | ||
| 0.101 | 0.055 | 0.101 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.054 | 0.012 | 0.057 | RNA-directed RNA polymerase stimulant | 0.057 0.012 DBMET00575 | DBMET00575 | |
| 0.052 | 0.01 | 0.052 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.035 0.029 DBMET00575 | ||
| 0.111 | 0.073 | 0.115 | Estrogen antagonist | 0.115 0.064 DBMET00575 | DBMET00575 | |
| 0.065 | 0.027 | 0.065 | Protein 50S ribosomal subunit inhibitor | 0.065 0.027 DBMET00575 | ||
| 0.147 | 0.109 | 0.175 | Platelet adhesion inhibitor | 0.175 0.085 DBMET00575 | DBMET00575 | |
| 0.107 | 0.074 | 0.123 | Interleukin 1b antagonist | 0.123 0.06 DBMET00575 | DBMET00575 | |
| 0.1 | 0.068 | 0.198 | Expectorant | 0.198 0.021 DBMET00575 | DBMET00575 | |
| 0.06 | 0.028 | 0.06 | Leukotriene B4 antagonist | 0.057 0.032 DBMET00575 | ||
| 0.036 | 0.006 | 0.036 | Hedgehog signaling activator | 0.032 0.009 DBMET00575 | ||
| 0.046 | 0.017 | 0.046 | Glucocorticoid antagonist | |||
| 0.044 | 0.017 | 0.047 | Glucose-6-phosphate dehydrogenase inhibitor | 0.047 0.014 DBMET00575 | DBMET00575 | |
| 0.027 | 0.006 | 0.027 | Progesterone receptor B antagonist | 0.025 0.007 DBMET00575 | ||
| 0.117 | 0.096 | 0.132 | Vanilloid 1 agonist | 0.132 0.063 DBMET00575 | DBMET00575 | |
| 0.169 | 0.149 | 0.302 | Hypoglycemic | 0.302 0.052 DBMET00575 | DBMET00575 | |
| 0.037 | 0.019 | 0.039 | Tubulin agonist | 0.039 0.017 DBMET00575 | DBMET00575 | |
| 0.052 | 0.034 | 0.052 | Estrogen agonist | 0.052 0.034 DBMET00575 | ||
| 0.027 | 0.011 | 0.028 | Prostaglandin F2 alpha agonist | 0.028 0.01 DBMET00575 | DBMET00575 | |
| 0.034 | 0.018 | 0.034 | Prostaglandin D2 agonist | 0.034 0.018 DBMET00575 | ||
| 0.138 | 0.127 | 0.149 | Interleukin antagonist | 0.149 0.118 DBMET00575 | DBMET00575 | |
| 0.032 | 0.022 | 0.034 | ATP citrate lysase inhibitor | 0.034 0.019 DBMET00575 | DBMET00575 | |
| 0.111 | 0.103 | 0.127 | Interleukin 1 antagonist | 0.127 0.079 DBMET00575 | DBMET00575 | |
| 0.014 | 0.006 | 0.014 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.014 0.006 DBMET00575 | ||
| 0.027 | 0.02 | 0.027 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.019 | 0.011 | 0.088 | 5-Alpha-reductase 1 inhibitor | 0.088 0.005 DBMET00575 | DBMET00575 | |
| 0.071 | 0.064 | 0.071 | Estrogen receptor alpha antagonist | 0.071 0.065 DBMET00575 | ||
| 0.02 | 0.017 | 0.022 | Corticosteroid-like | 0.022 0.014 DBMET00575 | DBMET00575 | |
| 0.018 | 0.015 | 0.018 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.137 | 0.136 | 0.137 | Antimitotic | |||
| 0.025 | 0.026 | 0.031 | Retinoid X gamma receptor antagonist | 0.031 0.011 DBMET00575 | DBMET00575 | |
| 0.073 | 0.075 | 0.125 | Ornithine decarboxylase inhibitor | 0.125 0.023 DBMET00575 | DBMET00575 | |
| 0.076 | 0.079 | 0.093 | Transcription factor NF kappa B stimulant | 0.093 0.046 DBMET00575 | DBMET00575 | |
| 0.018 | 0.03 | 0.022 | Retinoic acid gamma receptor agonist | 0.022 0.017 DBMET00575 | DBMET00575 | |
| 0.091 | 0.105 | 0.097 | TRPA1 agonist | 0.097 0.093 DBMET00575 | DBMET00575 | |
| 0.01 | 0.025 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 DBMET00575 | DBMET00575 | |
| 0.015 | 0.04 | 0.025 | Retinoid X beta receptor antagonist | 0.025 0.007 DBMET00575 | DBMET00575 | |
| 0.108 | 0.134 | 0.215 | Insulin secretagoues | 0.215 0.029 DBMET00575 | DBMET00575 | |
| 0.154 | 0.183 | 0.197 | Peptidyltransferase inhibitor | 0.197 0.103 DBMET00575 | DBMET00575 | |
| 0.013 | 0.047 | 0.023 | Retinoid X gamma receptor agonist | 0.023 0.016 DBMET00575 | DBMET00575 | |
| 0.079 | 0.117 | 0.143 | Mucolytic | 0.143 0.037 DBMET00575 | DBMET00575 | |
| 0.104 | 0.169 | 0.146 | Adenylate cyclase stimulant | 0.146 0.07 DBMET00575 | DBMET00575 | |
| 0.011 | 0.097 | 0.043 | Retinoid X receptor agonist | 0.043 0.021 DBMET00575 | DBMET00575 | |
| 0.145 | 0.259 | 0.2 | Antithrombotic | 0.2 0.177 DBMET00575 | DBMET00575 | |
| 0.098 | 0.225 | 0.22 | Platelet antagonist | 0.22 0.088 DBMET00575 | DBMET00575 | |
| 0.019 | 0.156 | 0.035 | Retinoid X receptor antagonist | 0.035 0.033 DBMET00575 | DBMET00575 | |
| 0.011 | 0.15 | 0.034 | Retinoid X alpha receptor agonist | 0.034 0.025 DBMET00575 | DBMET00575 | |
| 0.004 | 0.195 | 0.016 | Free fatty acid receptor 1 agonist | 0.016 0.014 DBMET00575 | DBMET00575 | |
| 0.043 | 0.242 | 0.096 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.096 0.058 DBMET00575 | DBMET00575 | |
| 0.138 | 0.341 | 0.19 | 5 Hydroxytryptamine uptake stimulant | 0.19 0.173 DBMET00575 | DBMET00575 | |
| 0.051 | 0.327 | 0.147 | Insulin sensitizer | 0.147 0.137 DBMET00575 | DBMET00575 | |
| 0.019 | 0.616 | 0.099 | Cell adhesion inhibitor | 0.099 0.09 DBMET00575 | DBMET00575 | |
| 0.004 | 0.718 | 0.015 | Integrin beta6 antagonist | 0.015 0.007 DBMET00575 | DBMET00575 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |